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Abstract
Interferon gamma (IFNc) is an important regulatory cytokine that can exert a pro-inflammatory effect in the gut, where it
has been shown to increase epithelial permeability via disruption of the tight junctions. Here we investigated the potential
for IFNc to regulate the adherens junction protein E-cadherin, an important mediator of normal epithelial tissue function,
using the model T84 human colonic epithelial cell line. IFNc (10 ng/ml) stimulated increased internalization of E-cadherin as
assessed by immunofluorescence microscopy; internalization was reversed when cells were treated with PP1 (125 nM), a Src
kinase-selective inhibitor. Immunoprecipitation studies demonstrated loss of E-cadherin from membrane fractions following
IFNc treatment and a corresponding increase in cytosolic E-cadherin and its binding partners, p120-catenin and beta-
catenin: effects that were Src-kinase dependent. E-cadherin and p120-catenin phosphorylation was increased by IFNc
treatment and siRNA studies showed this was dependent upon the Src-kinase isoform Fyn. E-cadherin ubiquitinylation and
subsequent proteasomal degradation stimulated by IFNc was found to be dependent upon Fyn and the E-cadherin-
selective ubiquitin ligase, Hakai. Use of Fyn and Hakai siRNA inhibited the internalization of E-cadherin as shown by
immunoblotting and confocal fluorescence microscopy. Finally, IFNc treatment resulted in a more fragile T84 cell monolayer
with increased cell detachment in response to physical stress, which was prevented by PP1 and siRNA targeting Fyn or
Hakai. Collectively, these results demonstrate a Fyn kinase-dependent mechanism through which IFNc regulates E-cadherin
stability and suggest a novel mechanism of disruption of epithelial cell contact, which could contribute to perturbed
epithelial barrier function.
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Introduction
The integrity of the intestinal epithelial monolayer constitutes
an important regulated barrier that controls access of the gut
microflora, an abundant population of commensal and potentially
pathogenic microbes, to the mucosa and thus is a key modulator of
immune-mediated inflammatory activity within the intestinal
submucosa [1]. Furthermore, increases in enteric epithelial
permeability often parallel the onset of inflammatory disease and
also potentially colorectal cancer [2]. As the association between
microbial-driven inflammation and cancer becomes more appar-
ent, a greater awareness of mechanisms of altered gut epithelial
function during inflammatory responses may lead to additional or
improved treatment strategies.
Interferon-gamma (IFNc) is a key inflammatory cytokine
primarily secreted by T cells and natural killer (NK) cells that
has a well-described role during intestinal inflammation [3,4].
IFNc stimulates increased intestinal epithelial permeability by
reducing tight junction stability (paracellular permeability) [5], and
our work, and that of others, has shown that IFNc signalling
through phosphatidylinositol 3-kinase (PI3K) and the Src-kinase
family member, Fyn, promotes increased epithelial uptake of
commensal bacteria and macromolecules in in vitro model systems
[6–8]. Thus, IFNc may serve to exacerbate inflammatory
responses via its effects on the epithelial barrier.
Src kinase activity has been widely-associated with epithelial
dysfunction. Src kinases have been linked to epithelial to
mesenchymal transition (EMT) in response to growth factors or
oxidative stress [9,10]. c-Src-mediated epithelial cell scattering has
been suggested as an important step during acquisition of
a transformed phenotype [11], and the Src-family Fyn kinase
has recently been identified as a potential catalyst for the
development of prostate cancer [12,13]. However, extensive
studies of Fyn kinase participation in the intestinal epithelial
response to IFNc have not been conducted.
A key mediator of the stability of the intestinal epithelium is the
adherens junction. E-cadherin is a critical intercellular junctional
protein that is maintained at the cell surface by interactions with
p120-catenin, beta-catenin and additional proteins mediating
adhesion to the actin cytoskeleton [14]. Loss of E-cadherin
function is associated with development of chronic inflammatory
diseases including Crohn’s disease [15]. E-cadherin is also
considered a tumour suppressor, as loss of E-cadherin expression
or activity is highly correlative to the onset of epithelial-derived
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internalization following epithelial cell exposure to acidic pH or
growth factors in vitro [17,18], and p120-catenin, whose key
function is to bind and stabilize E-cadherin, is known to be a Fyn
kinase substrate [19]. Thus, we sought to determine whether
IFNc-stimulated Fyn kinase activity affected epithelial adherens
junction stability, specifically the expression and location of E-
cadherin.
Here we show that IFNc stimulates increased internalization of
E-cadherin in the human colonic T84 epithelial cell line. E-
cadherin internalization was reduced by treatment with the Src
inhibitor PP1 and siRNA targeting Fyn, and by siRNA targeting
Hakai, which has been characterized as a Src-dependent, E-
cadherin-specific ubiquitin ligase. Blockade of Fyn or Hakai
reduced the fragility of cell-cell adhesion in IFNc-treated plastic-
grown T84 cell monolayers. The data illustrate that an adherens
junction-destabilizing pathway involving Fyn kinase and Hakai
can be activated by IFNc in T84 epithelia, and we speculate that
this could be relevant to epithelial cell-cell adhesion and
communication, and potentially enteric inflammatory disease.
Materials and Methods
Reagents and Antibodies
Cell culture supplements and pharmacologic inhibitors, were
purchased from Sigma-Aldrich (Oakville, Ontario, Canada) unless
otherwise indicated. The Src inhibitor PP1 was purchased from
Biomol (Enzo Life Sciences, Plymouth Meeting, PA, USA).
Recombinant human IFNc was from Ebioscience Inc. (San
Diego, CA, USA). Mouse anti-E-cadherin and mouse anti-beta-
catenin antibodies were purchased from BD Transduction Labs
(Mississauga, ON, Canada). Mouse anti-p120 catenin and mouse
anti-phosphotyrosine (clone 4G10) antibodies were purchased
from Upstate/Millipore (Billerica, MA, USA). Rabbit anti-
occludin was purchased from Zymed/Invitrogen (Carlsbad, CA).
Rabbit anti-zonula occludens (ZO-1) antibody was purchased
from Invitrogen. Goat anti-actin antibody, rabbit anti-CBLL/
Hakai, mouse anti-Fyn antibody and HRP-conjugated secondary
antibodies were from Santa Cruz Biotech (Santa Cruz, CA, USA).
AlexaFluor goat anti-mouse 488 and goat anti-rabbit 594
fluorescent secondary antibodies were purchased from Molecular
Probes/Invitrogen (Carlsbad, CA, USA).
Cell Culture
The immortalized human colon-derived T84 epithelial cell line
(ATCC, Manassas, VA, USA) was cultured at 37uC/5% CO2 in
1:1 Dulbecco’s modified Eagle’s Medium/Ham’s F-12 medium
supplemented with 2% (vol./vol.) penicillin-streptomycin, 1.5%
HEPES, 5% NaHCO3, 1% L-glutamine, 1% sodium pyruvate (all
from Invitrogen, Burlington, ON, Canada) and 10% fetal bovine
serum (PAA Laboratories, VWR International, Edmonton, AB,
Canada). All cytokine stimulations with IFNc were conducted
using 10 ng/ml recombinant cytokine (equivalent to 250 biological
units of activity/ml cell culture medium).
Transient Transfection of T84 Cells with Small Interfering
(si) RNA
siRNAs targeting Fyn and Hakai were created using the Stealth
siRNA oligomer design platform (Invitrogen). Target oligomer
sequences used in this study are as follows:
Fyn 59-GAGCGACAGCTATTGTCCTTTGGAA. Hakai 59 -
CAACATGTGCCACATGAGCA CTATA. The control siRNA
sequence used was 59-GAGACATCGTTACTGTTCGGAA.
Transfections were performed as previously described [8]. Briefly,
20 pM of siRNA in Lipofectamine 2000/Opti-MEM (500 mg/ml)
(Invitrogen) was added to suspension cultures of T84 cells (1610
6/
ml) in antibiotic-free FBS-containing culture medium. The cells
were then either seeded onto filter supports or 12-well culture
dishes and following an overnight incubation, adherent cells were
washed and transferred to antibiotic-containing culture medium.
Immunoprecipitation and Immunoblotting
One million T84 cells were seeded onto 12 mm
2 permeable
filter supports (Greiner Bio-One) in 12-well plates and cultured
until confluent as assessed by phase-contrast microscopy and
electrical confluence (transepithelial resistance (TER)$1000
V.mm
2 as measured by voltmeter and paired electrodes (Millipore)
was accepted as an electrically confluent monolayer). As indicated,
cell lysates were prepared following two washes with ice-cold
phosphate-buffered saline (PBS). For low-salt, detergent-free lysate
generation, cells were scraped into hypotonic Buffer A as described
in [20] supplemented with protease and phosphatase inhibitors
(CompleteH protease inhibitor cocktail (Roche/Mannheim),
1 mM sodium orthovanadate, 1 mM sodium fluoride). Lysates
were incubated with gentle agitation at 4uC for 30 min,
centrifuged at 10,0006g and supernatants were collected and
stored at -80uC. Protein concentrations were determined by
Bradford assay (Bio-Rad, Hercules, CA, USA). For isolation of
membrane or cytoskeletal components, T84 monolayers were
lysed in 1% sodium dodecyl sulphate (SDS)/PBS supplemented
with protease inhibitors as above. Isolation of equivalent quantities
of cell material was assured by adjustment to Triton X-100 protein
lysate concentrations of identically plated cell cultures. For
immunoprecipitation experiments, monolayers were extracted
using radioactive immunoprecipitation assay (RIPA) buffer
(100 mM NaCl, 24 mM Tris-Cl, 1% (vol./vol.) NP-40, 0.5%
sodium deoxycholate, 0.1% SDS) supplemented with CompleteH
protease inhibitor cocktail, sodium orthovanadate and sodium
fluoride). Four hundred mg of clarified cell lysates were incubated
in 2 mg/ml anti-E-cadherin antibody overnight at 4uC with gentle
agitation. Immune complexes were isolated by incubation with
EZ-link protein A-agarose beads (Sigma) at 4uC for 90 mins,
followed by two washes in RIPA buffer and one wash with PBS.
Immune complexes were eluted with 2X Laemmli buffer and set
aside for immunoblotting. Protein lysate immunoblotting was
performed by addition of 20 mg of lysates to Laemmli buffer,
which were subsequently boiled and resolved on 8% SDS-PAGE.
Separated proteins were blotted to Immobilon nitrocellulose
membranes (Millipore), and blots were blocked at room temper-
ature for 1 h in 5% non-fat milk/wash buffer (0.15% Tween-20/
Tris-buffered saline (TBS/T)). Primary antibodies (see Results)
were incubated in 1% bovine serum albumin/TBS/T (for
phosphoprotein analysis) or 5% non-fat milk/TBS/T (total
proteins) overnight at 4uC with gentle rocking. Blots were washed
three times in TBS/T and species-appropriate, HRP-conjugated
secondary antibodies were applied with gentle rocking for 1 h at
room temperature. Blots were washed, subjected to chemilumi-
nescence (Western LightningH PLUS, PerkinElmer, Waltham,
MA, USA) and subsequently exposed to Kodak XB-1 film
(Eastman Kodak, Rochester, NY, USA).
Densitometric quantification of phospho-E-cadherin and ubiqui-
tinylated-E-cadherinchemiluminescencewasperformedbyanalysis
of 16-bit JPEG blot images with Image J (version 1.45, NIH open
access software, W. Rasband). Measurement was conducted on
three replicate experimental immunoblots. Levels of phospho-E-
cadherin or ubiquitinylated-E-cadherin were normalized to total E-
cadherin immunoprecipitated per sample, and measurements
presented as relative ratios compared to non-stimulated control
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wereassessedandactinlevelsfromunbound,orflow-throughlysate,
were also verified.
Immunofluorescence Microscopy
T84 cells were plated (3610
5 cells/ml) onto glass coverslips in
12 well culture plates and grown to 70% confluent, at which time
IFNc6PP1 (125 nM) was added for 48 h. Coverslips were washed
three times in 4uC PBS, fixed in 4% paraformaldehyde (PFA),
washed three times in PBS and then blocked with 10% goat serum
for 1 h at room temperature. Monolayers were then incubated for
24 h at 4uC with mouse anti-E-cadherin (1:350) or anti-ZO-1
(1:100) antibody in PBS containing 10% goat serum and 0.1%
Tween. Following three washes with 1X PBS, monolayers were
incubated for 1 h at room temperature with AlexaFluor 488 goat
anti-mouse secondary antibody (1:500). DAPI (1:500) was added
for 1 min followed by 2 washes with 1X PBS, and coverslips were
mounted onto slides with Fluorosave (Calbiochem), allowed to dry
and stored in dark at 4uC. For visualization, slides were analyzed
using an Olympus 4100BX epifluorescence microscope (Olympus)
using the 40X objective lens: regions of monolayer were randomly
selected based on DAPI-identification of nuclei and then specific
immunofluorescence observed and images captured of that area.
Confocal laser scanning microscopy. For some experi-
ments, T84 cells were transfected with control, Fyn or Hakai
siRNA and seeded onto 6 mm
2 filter supports at 1610
5 cells/ml.
Following 72 h, cells were either left untreated or stimulated with
IFNc for 48 h, and then washed and fixed as above. Subsequently,
cells were stained with anti-E-cadherin antibody or anti-occludin
antibody (1:350) then with appropriate AlexaFluor secondary
antibodies (1:500), mounted and images captured on an Olympus
FV1000 confocal scanning fluorescent microscope (40X objective).
Images were collected and analyzed using FV10-ASW2.1 imaging
software (Olympus). As described above, cell viability and
localization were verified by nuclear DAPI staining. Determina-
tion of plane depth for analysis of occludin and E-cadherin was
Figure 1. The Src inhibitor PP1 blocks IFNc -stimulated E-cadherin internalization but does not affect the focal loss of zonula
occludens-1 (ZO-1). T84 cells were grown on glass coverslips and stimulated with IFNc (10 ng/ml, 48 h)6the Src inhibitor PP1 (125 nM). Left
panels: immunofluorescence microscopy of epithelial monolayers probed with a C-terminal-specific anti-E-cadherin antibody showed IFNc caused
increased E-cadherin internalization (*), which was inhibited by PP1 co-treatment, whereas in contrast (right panels) the focal discontinuities in the
distribution of ZO-1 induced by IFNc (arrows) was unaffected by PP1 co-treatment. Images collected are representative of two independent
experiments each using replicate epithelial cell monolayers per treatment, the junctional pattern with E-cadherin reflects the more diffuse adherens
junction which is in contrast to the more localized tight junction and associated plaque proteins (i.e. ZO-1). Scale bar=10 mm.
doi:10.1371/journal.pone.0038441.g001
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apical aspect of the epithelial layer. For each captured image E-
cadherin was imaged 0.2 mm deeper than the z-plane slice selected
for occludin localization.
Cell Detachment Assays
T84 cells were seeded on 12 mm
2 permeable filter supports as
described previously and grown to confluence and indicated by
TER$1000 V.cm
2. Where indicated, cells were transfected with
control, Fyn or Hakai targeted siRNA. Control siRNA-
transfected cells were either left untreated or treated with
IFNc6125 nM PP1. Fyn and Hakai siRNA-treated T84 cells
were also stimulated with IFNc. Following 48 h cytokine
treatment, TER was measured, the cells washed twice with
1 ml of 1X PBS and incubated for 15 minutes at 37uC in 500 ml
serum-free PBS. Subsequently, epithelial monolayers were rinsed
gently by pipeting with PBS (ten passes per monolayer) and
detached cells were collected into 1.5 ml Eppendorf tubes, placed
on ice, and centrifuged for 2 min at 30006g. Cell number was
assessed in two ways: (1) cells were re-suspended in 100 ml PBS
and were deposited onto slides (50 ml/preparation) by Cytospin,
stained with Cresyl violet, and then counted at 206 magnifica-
tion on a bright field inverted microscope. Counts were made for
each filter-grown epithelial monolayer, with a minimum of
triplicate filters used per treatment condition; (2) cell number was
approximated by quantification of total protein from the lysis of
collected detached cells (using 100 ml RIPA buffer/filter collect-
ed) using the Bradford assay. Protein was measured according to
a standard concentration curve using bovine serum albumin and
results were plotted graphically as mg of detached cell protein
isolated per filter; cell detachment was plotted as a percentage of
detachment relative to non-stimulated control (which was
assigned a percentage value of 100).
Statistical Analysis
Quantitative data are presented as mean6standard error of the
mean (SEM), with n values given as the number of epithelial
observations from replicate experiments. Single group compar-
isons were performed using Student’s t test and multiple group
statistical analysis was by a one-way analysis of variance (ANOVA)
followed by pair-wise post-hoc statistics. For cell detachment
studies, sample sizes were: non-stimulated (control), n=5; IFNc,
n=6; IFNc+PP1, n=5; IFNc+Fyn siRNA, n=5; IFNc+Hakai,
n=4. In all analyses a p,0.05 was accepted as a level of
statistically significant difference.
Results
E-cadherin Internalization is Increased Following IFNc
Treatment in a Src-dependent Manner
Previous research indicates that IFNc is a potent modulator of
intestinal tight junction form; however, relatively little attention
has focused on the role of IFNc in the regulation of the adherens
junction. IFNc has been reported to reduce surface expression of
E-cadherin in intestinal epithelial cells [21], but the intracellular
mechanism(s) responsible for this was not determined. Given our
data identifying a key role for the Src kinase Fyn in IFNc-evoked
increases in epithelial barrier function [8], we sought to determine
if Src activity was required for IFNc-evoked changes in E-cadherin
expression and localization in T84 epithelia. Initial studies used
epifluorescence microscopy to obtain a view of the global impact
of IFNc treatment on E-cadherin expression. Forty-eight hours
after IFNc treatment (10 ng/ml), there was a marked accumula-
tion of E-cadherin in cytosolic punctate structures and loss from
Figure 2. Increased solubilization of E-cadherin, p120-catenin
and beta-catenin by IFNc is Src-dependent. A) Representative
immunoblot showing differential solubility of E-cadherin, but not
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the pan-Src inhibitor PP1 (Figure 1). As a comparison with tight
junction structure, a 48 h treatment with IFNc resulted in the
expected focal discontinuities in ZO-1 [21], that was unaffected by
PP1 co-treatment (Figure 1).
IFNc Treatment Stimulates Increased Adherens Junction
Protein Accumulation in a Soluble Cytoplasmic Isolate
E-cadherin typically localizes to a highly insoluble cellular
fraction enriched with cytoskeletal components. We hypothesized
that IFNc stimulation would provoke a release of E-cadherin and
interacting proteins from the cell membrane to the cytosol, where
it would be extractable under less stringent isolation conditions.
Lysis of equivalent-density cell cultures in either detergent-free,
hypotonic conditions (termed low-salt buffer) or 1% SDS buffer (a
highly disruptive, anionic detergent buffer) indicated that the
majority of E-cadherin remained insoluble in non-stimulated T84
cells (Figure 2A). Conversely, equivalent amounts of the tight
junction protein occludin were identified by immunoblotting of
extracts retrieved by the low-salt and SDS buffers. Analysis of T84
cell extracts obtained with the low-salt buffer revealed increased E-
cadherin after 6 h of IFNc treatment, indicative of movement out
of the membrane and into the cytosol (Figure 2B). Similarly, co-
immunoprecipitation experiments employing a monoclonal anti-
body raised against a C-terminal E-cadherin epitope revealed
increased amounts of detectable p120-catenin and beta-catenin,
two binding partners of the C-terminal domain of E-cadherin, in
the low-salt extract: suggestive of the E-cadherin/p120 catenin/
beta-catenin disengagement from the cell membrane. No detect-
able E-cadherin, p120 catenin or beta-catenin could be recovered
from control, non-immune IgG immunoprecipitated samples (data
not shown). Inhibition of Src kinases with PP1 (125 nM,
a concentration that targets Fyn) reduced the solubility of all
three proteins following IFNc stimulation. In contrast to low-salt
extracted conditions, immunoprecipitation of high-salt lysis buffer-
extracted E-cadherin showed a minor and insignificant increase in
protein levels of both E-cadherin and p120-catenin following IFNc
treatment (Figure 2C).
IFNc-stimulated Tyrosine Phosphorylation of E-cadherin
and p120 Catenin is Fyn-dependent
We subsequently focused on identifying potential mechanisms
responsible for the IFNc-evoked increase in E-cadherin solubility
(i.e. dissociation from the membrane). Studies of v-Src transformed
cell lines suggest that increased tyrosine phosphorylation of E-
cadherin results in its dissociation from the cell surface; while
p120-catenin phosphorylation has been shown to affect its ability
to stabilize membrane-bound E-cadherin [22]. Anticipating that
an increase in phosphorylation of total E-cadherin would reflect
the increased amounts of solubilised E-cadherin (Figures 1 and 2),
epithelial cell lysis was conducted using RIPA buffer followed by
SDS-PAGE and immunoblotting. IFNc treatment evoked a gen-
eral increase in tyrosine phosphorylation in T84 cells (Figure 3A).
Following 6 h of IFNc stimulation, there was increased tyrosine
phosphorylation of E-cadherin, as demonstrated by immunoblot-
ting of immunoprecipitated E-cadherin with the anti-phosphotyr-
osine antibody 4G10. Consistent with our observation of altered
E-cadherin solubility, the Src inhibitor PP1 treatment strongly
inhibited IFNc-stimulated E-cadherin phosphorylation (Figure 3B).
We had previously reported that use of PP1 at low concentrations
could exclude potential off-target inhibition of tyrosine phosphor-
ylation by receptor tyrosine kinases such as EGFR or by inhibition
of Janus kinases, and we showed that Fyn was a major Src family
member stimulated by IFNc in T84 cells [8]. Therefore, the effects
of Fyn siRNA upon E-cadherin phosphorylation were examined.
Consistent with the data from PP1, immunoprecipitates of E-
cadherin demonstrated reduced tyrosine phosphorylation follow-
ing IFNc treatment in the presence of Fyn siRNA as compared to
control siRNA-treated lysates (Figure 3C). Additionally, IFNc-
stimulated p120-catenin phosphorylation was also reduced in T84
cells treated with Fyn siRNA (Figure 3C). Consistent with the
results presented in Figure 2B and C, control (non-immune) mouse
IgG antisera did not immunoprecipitate E-cadherin, validating
immunoblot experiments (data not shown).
E-cadherin Ubiquitinylation is Stimulated by IFNc and is
Dependent upon Fyn and Hakai
Next we wanted to identify factors that may promote the
internalization of tyrosine phosphorylated E-cadherin. Research
examining the mechanisms of epithelial cell infection by the
enteric pathogen Listeria monocytogenes has indicated that the
internalization of E-cadherin may occur in part via ubiquitin-
dependent mechanisms. Here, we found increased ubiquitinyla-
tion in whole cell lysates at 6–24 h post-IFNc treatment
(Figure 4A). Immunoprecipitated E-cadherin from T84 cells
treated 24 h previously with IFNc was ubiquitinylated (Ub), but
this was only apparent in samples from epithelia in which
proteasome activity was inhibited by MG132 (Figure 4B).
Conversely, treatment of T84 cells with chloroquine, an inhibitor
of lysosomal activity, did not prevent the degradation of Ub-E-
cadherin induced by IFNc. As an indicator of chloroquine activity,
we observed a decreased amount of lysosomal-associated E-
cadherin fragmentation. Cleavage of lysosomal-targeted E-cad-
herin is evidenced by a marked E-cadherin C-terminal 30 kDa
peptide [23]. The lower panel of Figure 4B shows the soluble
cytoplasmic fragments of E-cadherin, including an approximately
85 kDa peptide fragment released by cleavage of the extracellular
domain and a 30 kDa fragment consistent with the size of the
lysosomal-generated E-cadherin peptide. IFNc-stimulated T84
cell lysates demonstrated greater levels of 30 kDa E-cadherin, but
less of the protein fragment was present in cell lysates from
IFNc+chloroquine treated cultures (Figure 4B). Additionally, only
Ub-E-cadherin, not ‘unmodified’ E-cadherin levels, were mark-
edly reduced by MG132. We then focused on candidate
ubiquitinylation mechanisms that could direct E-cadherin to the
proteasome for degradation. Hakai is a phosphorylation-de-
pendent RING-type E3 ligase with a reported specificity for E-
cadherin [24]. Hakai-mediated ubiquitinylation of E-cadherin is
Src-dependent and promotes the proteasomal degradation of E-
cadherin [24,25]. Thus, we sought to determine whether IFNc-
stimulated E-cadherin phosphorylation by Fyn was required for
Hakai mediated ubiquitinylation of E-cadherin. The upper panels
of Figure 4C presented ubiquitinylation immunoblotting from
RIPA-isolated T84 whole cell lysates. Irrespective of treatment,
whole cell ubiquitin levels were only slightly modulated. However,
from E-cadherin immunoprecipitates (shown in the lower panels)
occludin, in low-salt buffer compared to high salt-1% SDS lysis buffer. B)
E-cadherin is associated with p120-catenin and beta-catenin and
complex solubility is increased by IFNc (10 ng/ml, 6 h) treatment as
shown by SDS-PAGE of detergent-free (low-salt) lysates immunopreci-
pitated with anti-E-cadherin antibody. Inclusion of PP1 (125 nM) inhibits
increased solubilization of E-cadherin/p120-catenin/beta-catenin
caused by IFNc. Data shown are representative of three independent
experiments. C) Immunoprecipitation of E-cadherin and p120-catenin
following lysis in high-salt-containing buffer shows only marginal
increase in expression in the IFNc treated epithelia. IgH and actin are
included as loading controls.
doi:10.1371/journal.pone.0038441.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38441Figure 3. IFNc-stimulated phosphorylation of E-cadherin and p120-catenin is reduced by PP1 and Fyn kinase siRNA. A) Time course
analysis reveals a generalized increase in tyrosine phosphorylation in T84 whole cell lysates treated with IFNc (10 ng/ml). B) Tyrosine phosphorylation
of E-cadherin following IFNc stimulation (6 h) was reduced by PP1 (125 nM) as demonstrated in a representative immunoblot of E-cadherin-
immunoprecipitated T84 cell lysates and quantified by densitometric assessment conducted on the result of three representative experiments. C)
Increased E-cadherin and p120 catenin tyrosine phosphorylation evoked by IFNc was reduced in cells in which Fyn expression (lowest panels) had
been knocked-down by siRNA. Actin and IgH are included as loading controls. Graph depicts densitometry analysis of phospho-E-cadherin
immunoblots from three experiments (mean6SEM; *, p,0.05 compared to control (Unstim) and IFNc+Fyn siRNA treated epithelia).
doi:10.1371/journal.pone.0038441.g003
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24 h IFNc exposure were significantly increased. In contrast,
IFNc-stimulated T84 cells treated with Fyn siRNA demonstrated
a significant reduction of ubiquitinylation, consistent with a re-
quirement for tyrosine phosphorylation of E-cadherin prior to
ubiquitinylation (Figure 4C). Hakai co-immunoprecipitated with
E-cadherin following IFNc treatment, and this association was
reduced in Fyn siRNA-treated epithelia. We then assessed the
effects of Hakai siRNA upon ubiquitinylation of E-cadherin
(Figure 4D). Similarly to Fyn siRNA treatment, whole cell lysate
immunoblots (upper panels) showed marginal changes to overall
ubiquitinylation levels, but immunoprecipitation of E-cadherin
(lower panels) indicated an IFNc-stimulated increase in Ub-E-
cadherin. Hakai siRNA-treated T84 epithelia displayed signifi-
cantly reduced levels of Ub-E-cadherin following IFNc treatment.
Fyn- and Hakai-specific siRNA Reduce IFNc-stimulated E-
cadherin Internalization
Initial studies indicated that IFNc treatment of T84 epithelia
resulted in a relatively rapid internalization of E-cadherin
(Figure 2B), but what of the effects, if any, in a longer time-
frame? To address this, we used the proteasome inhibitor,
MG132, to prevent the degradation of E-cadherin and so enhance
its detection. When using low-salt lysis buffer, we found that the
levels of soluble cytosolic E-cadherin were still elevated 48 h after
IFNc-treatment and that this was substantially reduced by Fyn but
not control siRNA treatment of the epithelia (Figure 5A). This
contrasted with the detection of E-cadherin in T84 cell extracts
produced by lysis with a high-salt, Triton X-100-based buffer,
where only slight increases in E-cadherin protein were observed
following IFNc treatment relative to either controls or IFNc+Fyn
siRNA-treated epithelia (Figure 5A, lower panel). Consistent with
the effects of Fyn, Hakai siRNA reduced the IFNc-stimulated
solubilisation of E-cadherin (Figure 5B). Again, there was only
a modest increase in E-cadherin detected in Triton X-100, high
salt lysis buffer-extracted lysates of IFNc-treated T84 cells.
Figure 5C presents representative confocal immunofluorescence
images showing membrane distribution of E-cadherin and
occludin (images were collected at a consistent z-plane depth for
E-cadherin and occludin, based on the first observable occludin
immunoreactivity). Treatment with Fyn or Hakai siRNA reduced
the loss of adherens junction-localized E-cadherin following 48 h
of exposure to IFNc. Conversely, IFNc-stimulated disruption of
tight junctions, indicated by dissociation of occludin, was neither
affected by Fyn nor Hakai siRNA.
T84 Cell Dissociation Stimulated Agitation of IFNc-
Treated Monolayer is Inhibited by Fyn and Hakai siRNA
A key functional measure of E-cadherin stability is the integrity
of cell-cell contacts. The drop in TER that is consistently observed
48 h after IFNc-treatment (measured before the gentle flushing)
was unaffected by PP1 co-treatment or knock-down of Fyn kinase
or Hakai with siRNA (Figure 6A), which is consistent with the
inability of either treatment to prevent the disruption in the
pattern of the tight-junction protein occludin by IFNc (Figure 5C)
and the inability of PP1 to prevent the subtle changes in ZO-1
distribution (Figure 1). However, while the monolayer remained
intact it was more fragile as demonstrated by the substantial
increase in cell detachment evoked by a gentle, consistent flushing
with warm PBS which could mimic some aspects of shear stress or
fluid transit along the intestine. As shown both by enumeration of
detached cells (Figure 6B) and quantification of total protein in
cells collected from the culture medium (Figure 6C), PPI inhibition
of Src kinases significantly inhibited IFNc-stimulated cell de-
tachment, as did siRNA knock-down of Fyn kinase or Hakai in
T84 epithelia.
Discussion
The enteric epithelial layer is an important active participant in
mucosal immunity through the secretion of anti-microbial
peptides, promotion of oral tolerance and formation of a barrier
to the entry of lumen-derived material [1,26]. Epithelial injury can
contribute to the exacerbation of inflammatory responses and
affect the rate of restoration of homeostasis following infection,
potentially leading to prolonged inflammation [1]. Indeed,
disruption of the integrity of the gut epithelium (or its function)
is associated with chronic inflammatory diseases, such as Crohn’s
disease and ulcerative colitis [27]. In addition to the direct effects
of long-term injury to the epithelium, chronic inflammation can
contribute to the development of cancer, a relationship that is
increasingly recognized in the context of inflammatory bowel
diseases and colorectal cancer [28]. Thus, there is considerable
value in understanding the full impact of inflammatory signals
such as IFNc on the control of enteric epithelial cell-cell contacts.
The molecular and cellular mechanisms that program the gut to
remain in a chronic diseased state are poorly defined. IFNc is an
established immune effector molecule associated with intestinal
inflammation in humans and animal models. Aside from its key
function as an immune-stimulatory cytokine, in vitro study (and
a lesser number of in vivo observations [3,29]) indicate that IFNc
can significantly disrupt epithelial barrier function [30], thereby
potentially exacerbating inflammation by facilitating a breach of
the epithelial layer and entry of antigen and microbes into the
mucosa. Therefore, IFNc is of particular interest since elucidation
of the signal transduction pathways that promote immune function
as opposed to those which elicit alterations in cell-cell interactions
and decrease epithelial barrier function may uncover unique
targets for therapeutic intervention. Extensive research efforts are
revealing the molecular assembly of the epithelial tight junction,
the structure primarily responsible for restricting the movement of
material between adjacent cells, and how pro-inflammatory
cytokines, including IFNc, affect the tight junction [26,30,31].
Comparatively little attention has been directed towards assessing
Figure 4. Ubiquitinylation of E-cadherin stimulated by IFNc is inhibited by siRNA targeting Fyn kinase and Hakai. A) Representative
immunoblot showing a time-dependent increase in total ubiquitinylation induced in T84 epithelial cells treated with IFNc (10 ng/ml). B) Upper panels
demonstrate that treatment with the proteosome inhibitor, MG132 (500 nM), but not chloroquine (CQ, 5 mM; reduces lysosomal acidification)
prevents the IFNc-evoked degradation of E-cadherin as shown by the presence of ubiquitinylated E-cadherin. Lower panels show cytoplasmic
cleavage products of E-cadherin. Levels of the 30 kDa lysosomal fragment (arrowhead) were increased following IFNc treatment but were reduced in
IFNc+chloroquine-treated samples. C) Immunoprecipitated E-cadherin demonstrated ubiquitinylation following IFNc stimulation which was reduced
following Fyn siRNA. E3 ubiquitin ligase Hakai is co-immunoprecipitated with E-cadherin following IFNc stimulation but is reduced in Fyn siRNA
treated epithelia. Densitometric analysis (performed in triplicate) is shown below a representative immunoblot. Whole lysates (input) demonstrate
knockdown of Fyn by siRNA. D) Hakai siRNA inhibits E-cadherin ubiquitinylation; whole cell lysates indicate Hakai knockdown achieved by siRNA.
Densitometry is shown below a representative immunoblot (mean6SEM; *, p,0.05 compared to controls (Unstim) and IFNc+Fyn (or Hakai) siRNA
treated epithelia; actin and IgH are included as loading controls).
doi:10.1371/journal.pone.0038441.g004
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beneath the tight junction, the formation of the adherens junction
is considered as a critical forerunner to development of the tight
junction and hence epithelial monolayer formation.
Here, using a series of molecular analyses and the human T84
epithelial cell line (a model often used to define principles of the
control of epithelial permeability [32–34]), we have confirmed that
E-cadherin expression is affected by IFNc [21] and provide
evidence in support of a requirement for Fyn kinase in IFNc-
evoked loss of E-cadherin from the adherens junction. These data
add to growing awareness that Src-kinase, including Fyn, activity
affects the stability of E-cadherin at the cell surface: Src kinases
promote the phosphorylation of E-cadherin at C-terminal residues
associated with removal of E-cadherin from the cell membrane
Figure 5. Hakai siRNA inhibits IFNc-stimulated internalization of E-cadherin. Low salt, detergent-free lysis of MG132 (500 nM)-pretreated
T84 cells reveal that IFNc-stimulated (10 ng/ml, 48 h) internalization of E-cadherin is reduced in presence of A) Fyn and B) Hakai siRNA. High-salt
lysates do not demonstrate as dramatic an increase in solubility relative to low-salt lysis (lower panels). Data are representative of two experiments for
each lysis preparation. C) Confocal photomicrographs of immunofluorescent detection of E-cadherin and occludin localization. IFNc treatment
disrupts the pattern of E-cadherin (adherens junction) and occludin (tight junction) distribution, and treatment with Fyn kinase and Hakai siRNA
partially abrogates the displacement of E-cadherin but not occludin from the peri-junctional region. Data shown are representative of three
experiments for Fyn, two experiments for Hakai. Scale bar=10 mm.
doi:10.1371/journal.pone.0038441.g005
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the juxtamembrane domain of E-cadherin, a critical cytoplasmic
region that mediates E-cadherin membrane localization [36]; the
E-cadherin binding partners, p120-catenin and beta-catenin, are
phosphorylated by Src kinases [19]; and p120-catenin, a factor
required for stable integration of E-cadherin into the cell
membrane, is phosphorylated by Fyn [37]. In addition, phos-
phorylation of p120-catenin facilitates the association of E3-like
ligase Hakai. Consistent with these findings, our data support
a model whereby IFNc causes removal of E-cadherin from the
epithelial surface via the mobilization of Fyn kinase and sub-
sequent targeting for degradation via the E3-like ligase, Hakai.
Thus, these novel data highlight an additional mechanism through
which epithelial cell-cell adhesion may be disrupted during
ongoing inflammatory reactions involving IFNc.
The impact of destabilization of the adherens junction on an
epitheliums barrier function once tight junctions have formed is
unclear [38]. Certainly TER is a direct reflection of the tight
junction as perseverance of E-cadherin did not ablate the ability of
IFNc to reduce TER; however, E-cadherin does provide a level of
cell-cell stability since its loss leads to a more friable monolayer.
Structural components of the tight junction, such as claudins and
occludin, cycle rapidly into and out-of the epithelial cell
membrane and are anchored to the cytoskeleton via adaptor
proteins, principally isoforms of zonula occludens (ZO) [39]. ZO-1
and the adherens junction proteins can interact and both play
important roles in establishing cell polarity [40], which is essential
for proper function of the enteric epithelium. For example, E-
cadherin can physically interact with polarity-promoting and
regulatory factors, such as the tumour suppressing phosphatase
PTEN [41,42] and Par3/Bazooka [43], respectively. Consequent-
ly reduced surface expression of E-cadherin may affect the
maintenance of the epithelial tight junction, the ability of
enterocytes to spread and heal a wound, and to restore a polarized
monolayer with the ability to vectorially transport electrolytes.
An intriguing alternative possibility is that IFNc-stimulation of
E-cadherin internalization might have a protective function. For
instance, the bacterial pathogen Listeria monocytogenes can use E-
cadherin as a receptor for entry into the enterocyte and hence
removal of E-cadherin from the adherens junction could limit L.
monocytogenes invasion [44].
Src-family kinases possess oncogenic properties: Src-mediated
destabilization of E-cadherin has been presented as a molecular
mechanism for malignancy in tissues including the colonic
epithelium [9,16,45] and emerging data suggest that Fyn kinase
participates in the malignant transformation of prostate epithelium
[13,46]. Further, though unrelated to its ubiquitin ligase activity,
Hakai may be considered an oncogenic factor via its ability to
modify RNA splicing [47]. Also, Hakai, C-terminal fragments of
E-cadherin, p120-catenin and beta-catenin have been localized to
the nucleus in in vitro cell systems [47,48]. So while focusing on
IFNc regulation of structural elements of the epithelial barrier we
should not overlook IFNc-Fyn-Hakai activity in the contexts of cell
signalling, gene regulation and cancer. As the field of inflamma-
tion-driven cancer (e.g. colorectal cancer) gains momentum we
speculate that IFNc regulation of E-cadherin and associated
signalling molecules, such as beta-catenin, is worthy of substantive
investigation and has the potential to yield key insights into the
regulation of the malignancy.
Figure 6. Increased cell detachment evoked by fluid shear in
IFNc-treated T84 epithelial cell monolayers is reduced by
siRNA knock-down of Fyn kinase and Hakai. A) Electrically
confluent T84 cell monolayers treated with IFNc (10 ng/ml, 48 h,
control siRNA) displayed the expected drop in transepithelial resistance
(TER) that was unaffected by PP1 (125 nM) co-treatment or by siRNA
knockdown of Fyn kinase or the E3-like ligase, Hakai. In contrast, cell
detachment from the monolayer caused by gentle fluid shear stress
evoked by IFNc, and assessed by (B) cell counts and (C) total protein
from suspended cells was statistically significantly reduced by PP1, and
to a lesser extent by siRNA targeting Fyn kinase or Hakai (measurement
of cell detachment as detected by amount of cellular protein from
washed cells (mean6SEM; n=426 monolayer preparations from 2
experiments; * and #,p ,0.05 compared to control (Unstim) mono-
layers and IFNc treatment (+ control siRNA), respectively; data are
representative of three experiments).
doi:10.1371/journal.pone.0038441.g006
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a pivotal signal in specific aspects of IFNc control of epithelial
function. Not only is it central to the regulation of macromolecular
permeability [8], but via its affect on E-cadherin it can modify cell-
cell interactions, intracellular signalling pathways and possibly also
oncogenic processes as well. These effects contrast with the
accepted role of IFNc as an anti-cancer factor due to its activation
of anti-tumour cell types, namely cytotoxic T cells, macrophages
and natural killer cells [49]. Thus, we propose that Fyn kinase
could be exploited to inhibit many of the pathological effects of
IFNc on intestinal epithelial cells, and possibly epithelia in general.
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